US 7084271
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7084271 (Pyrazolopyrimidines as cyclin dependent kinase inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18